Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
Abstract Background Real-world data on treatment patterns/outcomes for metastatic pancreatic cancer (mPAC) are limited. This study aims to assess real-world treatment patterns, survival outcomes, and prognostic/predictive factors in patients with mPAC. Methods Retrospective, observational, chart-rev...
Main Authors: | Julien Taieb, Thomas Seufferlein, Michele Reni, Daniel H. Palmer, John A. Bridgewater, Antonio Cubillo, Gerald W. Prager, Alice Vermeire, Fabienne Hédouin-Biville, Zhaoyang Teng, Teresa Macarulla |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11377-1 |
Similar Items
-
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients
by: Frederik J. Hansen, et al.
Published: (2024-09-01) -
New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
by: Rocío del Campo-Pedrosa, et al.
Published: (2024-10-01) -
Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
by: Rocío del Campo-Pedrosa, et al.
Published: (2025-01-01) -
Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry
by: Jasmin Schuhbaur, et al.
Published: (2024-10-01) -
Causal association of dietary factors with five common cancers: univariate and multivariate Mendelian randomization studies
by: Lin Yang, et al.
Published: (2024-07-01)